Lilly Schizophrenia Awareness

Eli Lilly and Company is a leading innovation-driven corporation committed to developing best-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions.

In 1996, the World Psychiatric Association, with funding from Eli Lilly and Company, initiated a global program to fight the stigma and discrimination associated with schizophrenia. To help implement this public awareness campaign, the WPA asked closerlook to strategize an international communication plan. closerlook worked closely with the WPA to create “Open the Doors,” an integrated media program with focused anti-stigma messages targeting specific interest groups. OpenTheDoors.com contains a rich repository of program and medical information developed by closerlook with the help of mental health professionals from over 30 countries. Audio clips featuring individual testimonials about living with schizophrenia and the "Open the Doors" program help to personalize the site.